首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives.
【2h】

Antitrypanosomal activity of purine nucleosides can be enhanced by their conversion to O-acetylated derivatives.

机译:嘌呤核苷的抗胰锥虫活性可通过将其转化为O-乙酰化衍生物来增强。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fifteen purine nucleosides and their O-acetylated ester derivatives were examined for in vitro antitrypanosomal activity against the LAB 110 EATRO isolate of Trypanosoma brucei brucei and two clinical isolates of Trypanosoma brucei rhodesiense. Initial comparisons of activity were made for the LAB 110 EATRO isolate. Three nucleoside analogs exhibited no significant activity (50% inhibitory concentrations [IC50s] of > 100 microM), whether they were O acetylated or unacetylated; three nucleosides showed almost equal activity (IC50s of < 5 microM) for the parent compound and the O-acetylated derivative; nine nucleosides showed significantly improved activity (> or = 3-fold) upon O acetylation; of these nine analogs, six displayed activity at least 10-fold greater than that of their parent nucleosides. The most significant results were those for four apparently inactive compounds which, upon O acetylation, displayed IC50s of < or = 25 microM. When the series of compounds was tested against T. brucei rhodesiense isolates (KETRI 243 and KETRI 269), their antitrypanosomal effects were comparable to those observed for the EATRO 110 strain. Thus, our studies of purine nucleosides have determined that O acetylation consistently improved their in vitro antitrypanosomal activity. This observed phenomenon was independent of their cellular enzyme targets (i.e., S-adenosylmethionine, polyamine, or purine salvage pathways). On the basis of our results, the routine preparation of O-acetylated purine nucleosides for in vitro screening of antitrypanosomal activity is recommended, since O acetylation transformed several inactive nucleosides into compounds with significant activity, presumably by improving uptake characteristics. O-acetylated purine nucleosides may offer in vivo therapeutic advantages compared with their parent nucleosides, and this possibility should be considered in future evaluations of this structural class of trypanocides.
机译:检查了十五种嘌呤核苷及其O-乙酰化酯衍生物对布鲁氏锥虫的LAB 110 EATRO分离株和杜氏布鲁氏锥虫的两个临床分离株的体外抗锥虫活性。初步比较了LAB 110 EATRO分离物的活性。三种核苷类似物,无论是O乙酰化还是未乙酰化,均无显着活性(50%抑制浓度[IC50s]> 100 microM)。三个核苷对母体化合物和O-乙酰化衍生物的活性几乎相同(IC50 <5 microM); O乙酰化后,九种核苷显示出显着改善的活性(>或= 3倍);在这9种类似物中,有6种显示出的活性比其亲本核苷的活性至少高10倍。最显着的结果是四种明显无活性的化合物的结果,这些化合物在O乙酰化后显示的IC50≤25 microM。当针对罗氏布鲁氏菌分离株(KETRI 243和KETRI 269)测试该系列化合物时,其抗胰锥虫作用与EATRO 110菌株观察到的相当。因此,我们对嘌呤核苷的研究已经确定,O乙酰化能够持续改善其体外抗胰体锥虫的活性。观察到的现象与它们的细胞酶靶标无关(即S-腺苷甲硫氨酸,多胺或嘌呤挽救途径)。根据我们的研究结果,建议常规制备O-乙酰化嘌呤核苷以体外筛选抗锥虫活性,因为O乙酰化可能将几种非活性核苷转化为具有显着活性的化合物,大概是通过改善摄取特性。与它们的亲本核苷相比,O-乙酰化嘌呤核苷可能提供体内治疗优势,并且在对这种锥虫的结构类别进行未来评估时应考虑这种可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号